相关实验视频
Updated: Sep 13, 2025

10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
10.6K
[扩散性大B细胞淋巴瘤的老年患者的预后因素及其治疗结果.]
L O Ametova1, V B Kaliberdenko1, A A Yatsenko1
1S.I.Georgievsky Medical Institute, V.I.Vernadsky Crimean Federal University, 5/7 blvd. Lenin, Simferopol 295051, Republic of Crimea, Russian Federation,
Advances in gerontology = Uspekhi gerontologii
|August 3, 2025
概括
标准的R-CHOP治疗对于患有扩散型大B细胞淋巴瘤 (DLBCL) 的老年患者至关重要. 这种治疗提供了生存益处,显示出与DLBCL的年轻患者相似的结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床医学 临床医学
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Survival Analysis
455
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
455

